11
IRUS Total
Downloads
  Altmetric

Analysis of blood and nasal epithelial transcriptomes to identify mechanisms associated with control of SARS-CoV-2 viral load in the upper respiratory tract

File Description SizeFormat 
Supp_Table_1.xlsxSupporting information17.73 kBMicrosoft Excel XMLView/Open
Supp_Table_2.xlsxSupporting information256.4 kBMicrosoft Excel XMLView/Open
Supp_Table_3.xlsxSupporting information10.5 kBMicrosoft Excel XMLView/Open
Supp_Table_4.xlsxSupporting information11.12 kBMicrosoft Excel XMLView/Open
Supp_Table_5.xlsxSupporting information11.56 kBMicrosoft Excel XMLView/Open
Supp_Table_6.xlsxSupporting information12.54 kBMicrosoft Excel XMLView/Open
Supp_Table_7.xlsxSupporting information201.4 kBMicrosoft Excel XMLView/Open
Supp_Table_8.xlsxSupporting information15.91 kBMicrosoft Excel XMLView/Open
Supp_Table_9.xlsxSupporting information30.61 kBMicrosoft Excel XMLView/Open
PIIS0163445323005406.pdfPublished version2.85 MBAdobe PDFView/Open
Title: Analysis of blood and nasal epithelial transcriptomes to identify mechanisms associated with control of SARS-CoV-2 viral load in the upper respiratory tract
Authors: Moradi Marjaneh, M
Challenger, J
Salas, A
Gómez-Carballa, A
Sivananthan, A
Rivero-Calle, I
Barbeito-Castiñeiras, G
Foo, C
Wu, Y
Liew, F
Jackson, H
Habgood-Coote, D
D'Souza, G
Nichols, S
Wright, V
Levin, M
Kaforou, M
Thwaites, R
Okell, L
Martinon-Torres, F
Cunnington, A
PERFORM Consortium
GEN-COVID Study Group
Item Type: Journal Article
Abstract: Objectives: The amount of SARS-CoV-2 detected in the upper respiratory tract (URT viral load) is a key driver of transmission of infection. Current evidence suggests that mechanisms constraining URT viral load are different from those controlling lower respiratory tract viral load and disease severity. Understanding such mechanisms may help to develop treatments and vaccine strategies to reduce transmission. Combining mathematical modelling of URT viral load dynamics with transcriptome analyses we aimed to identify mechanisms controlling URT viral load. Methods: COVID-19 patients were recruited in Spain during the first wave of the pandemic. RNA sequencing of peripheral blood and targeted NanoString nCounter transcriptome analysis of nasal epithelium were performed and gene expression analysed in relation to paired URT viral load samples collected within 15 days of symptom onset. Proportions of major immune cells in blood were estimated from transcriptional data using computational differential estimation. Weighted correlation network analysis (adjusted for cell proportions) and fixed transcriptional repertoire analysis were used to identify associations with URT viral load, quantified as standard deviations (z-scores) from an expected trajectory over time. Results Eighty-two subjects (50% female, median age 54 years (range 3–73)) with COVID-19 were recruited. Paired URT viral load samples were available for 16 blood transcriptome samples, and 17 respiratory epithelial transcriptome samples. Natural Killer (NK) cells were the only blood cell type significantly correlated with URT viral load z-scores (r = −0.62, P = 0.010). Twenty-four blood gene expression modules were significantly correlated with URT viral load z-score, the most significant being a module of genes connected around IFNA14 (Interferon Alpha-14) expression (r = −0.60, P = 1e-10). In fixed repertoire analysis, prostanoid-related gene expression was significantly associated with higher viral load. In nasal epithelium, only GNLY (granulysin) gene expression showed significant negative correlation with viral load. Conclusions: Correlations between the transcriptional host response and inter-individual variations in SARS-CoV-2 URT viral load, revealed many molecular mechanisms plausibly favouring or constraining viral replication. Existing evidence corroborates many of these mechanisms, including likely roles for NK cells, granulysin, prostanoids and interferon alpha-14. Inhibition of prostanoid production and administration of interferon alpha-14 may be attractive transmission-blocking interventions.
Issue Date: Dec-2023
Date of Acceptance: 16-Oct-2023
URI: http://hdl.handle.net/10044/1/107456
DOI: 10.1016/j.jinf.2023.10.009
ISSN: 0163-4453
Publisher: Elsevier
Start Page: 538
End Page: 550
Journal / Book Title: Journal of Infection
Volume: 87
Issue: 6
Copyright Statement: © 2023 The Author(s). Published by Elsevier Ltd on behalf of The British Infection Association. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)
Publication Status: Published
Online Publication Date: 2023-10-18
Appears in Collections:Department of Infectious Diseases
National Heart and Lung Institute
Faculty of Medicine
Imperial College London COVID-19
School of Public Health



This item is licensed under a Creative Commons License Creative Commons